Consistent with those results, neutralizing IL-21R by its antibody abrogates IMQ-induced epidermal thickening, MDSC migration, and Th17 infiltration (Figure 5), indicating IL-21 may be a potential therapeutic target for psoriasis treatment. This evidence concerns the gene IL21R and psoriasis.